1. Home
  2. FSTR vs ALLO Comparison

FSTR vs ALLO Comparison

Compare FSTR & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

N/A

Current Price

$38.07

Market Cap

442.3M

Sector

Industrials

ML Signal

N/A

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

N/A

Current Price

$0.62

Market Cap

452.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSTR
ALLO
Founded
1902
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.3M
452.6M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
FSTR
ALLO
Price
$38.07
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
★ $45.50
$9.00
AVG Volume (30 Days)
29.8K
★ 11.4M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.09
EPS
★ 1.07
N/A
Revenue
★ $540,009,000.00
N/A
Revenue This Year
$6.53
N/A
Revenue Next Year
$4.30
$180.53
P/E Ratio
$37.13
★ N/A
Revenue Growth
★ 1.74
N/A
52 Week Low
$25.66
$0.65
52 Week High
$45.81
$4.46

Technical Indicators

Market Signals
Indicator
FSTR
ALLO
Relative Strength Index (RSI) 47.74 17.76
Support Level $36.53 N/A
Resistance Level $38.92 $2.22
Average True Range (ATR) 1.62 0.09
MACD -0.19 -0.03
Stochastic Oscillator 31.39 0.05

Price Performance

Historical Comparison
FSTR
ALLO

About FSTR L.B. Foster Company

L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Share on Social Networks: